Literature DB >> 17893221

Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas.

S Chawla1, S Wang, R L Wolf, J H Woo, J Wang, D M O'Rourke, K D Judy, M S Grady, E R Melhem, H Poptani.   

Abstract

BACKGROUND AND
PURPOSE: Noninvasive grading of gliomas remains a challenge despite its important role in the prognosis and management of patients with intracranial neoplasms. In this study, we evaluated the ability of cerebral blood flow (CBF)-guided voxel-by-voxel analysis of multivoxel proton MR spectroscopic imaging ((1)H-MRSI) to differentiate low-grade from high-grade gliomas.
MATERIALS AND METHODS: A total of 35 patients with primary gliomas (22 high grade and 13 low grade) underwent continuous arterial spin-labeling perfusion-weighted imaging (PWI) and (1)H-MRSI. Different regions of the gliomas were categorized as "hypoperfused," "isoperfused," and "hyperperfused" on the basis of the average CBF obtained from contralateral healthy white matter. (1)H-MRSI indices were computed from these regions and compared between low- and high-grade gliomas. Using a similar approach, we applied a subgroup analysis to differentiate low- from high-grade oligodendrogliomas because they show different physiologic and genetic characteristics.
RESULTS: Cho(glioma (G)/white matter (WM)), Glx(G/WM), and Lip+Lac(G)/Cr(WM) were significantly higher in the "hyperperfused" regions of high-grade gliomas compared with low-grade gliomas. Cho(G/WM) and Lip+Lac(G)/Cr(WM) were also significantly higher in the "hyperperfused" regions of high-grade oligodendrogliomas. However, metabolite ratios from the "hypoperfused" or "isoperfused" regions did not exhibit any significant differences between high-grade and low-grade gliomas.
CONCLUSION: The results suggest that (1)H-MRSI indices from the "hyperperfused" regions of gliomas, on the basis of PWI, may be helpful in distinguishing high-grade from low-grade gliomas including oligodendrogliomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893221      PMCID: PMC8134179          DOI: 10.3174/ajnr.A0673

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  55 in total

Review 1.  Glioma classification: a molecular reappraisal.

Authors:  D N Louis; E C Holland; J G Cairncross
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Membrane phospholipid degradation and protein kinase C for cell signalling.

Authors:  Y Nishizuka
Journal:  Neurosci Res       Date:  1992-10       Impact factor: 3.304

3.  Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.

Authors:  L L Cheng; I W Chang; D N Louis; R G Gonzalez
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

4.  Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.

Authors:  Carles Majós; Juli Alonso; Carles Aguilera; Marta Serrallonga; Juan J Acebes; Carles Arús; Jaume Gili
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

5.  Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement.

Authors:  W A Hall; A Martin; H Liu; C L Truwit
Journal:  J Magn Reson Imaging       Date:  2001-01       Impact factor: 4.813

Review 6.  Oligodendroglioma: pathology and molecular biology.

Authors:  Herbert H Engelhard; Ana Stelea; Elizabeth J Cochran
Journal:  Surg Neurol       Date:  2002-08

7.  Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.

Authors:  D Zagzag; H Zhong; J M Scalzitti; E Laughner; J W Simons; G L Semenza
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

8.  Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval.

Authors:  J E Rosenberg; D K Lisle; J A Burwick; K Ueki; A von Deimling; H W Mohrenweiser; D N Louis
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

9.  Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.

Authors:  A von Deimling; D N Louis; K von Ammon; I Petersen; O D Wiestler; B R Seizinger
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

10.  Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study.

Authors:  A Rosemary Tate; Carles Majós; Angel Moreno; Franklyn A Howe; John R Griffiths; Carles Arús
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

View more
  39 in total

Review 1.  Applications of imaging technology in radiation research.

Authors:  MingDe Lin; Edward F Jackson
Journal:  Radiat Res       Date:  2012-03-08       Impact factor: 2.841

Review 2.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

3.  Arterial spin labeling of hemangioblastoma: differentiation from metastatic brain tumors based on quantitative blood flow measurement.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Kazufumi Kikuchi; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2011-11-10       Impact factor: 2.804

Review 4.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

5.  Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.

Authors:  Mandy Kim Rau; Christian Braun; Marco Skardelly; Jens Schittenhelm; Frank Paulsen; Benjamin Bender; Ulrike Ernemann; Sotirios Bisdas
Journal:  J Neurooncol       Date:  2014-08-27       Impact factor: 4.130

6.  3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.

Authors:  Q Zeng; B Jiang; F Shi; C Ling; F Dong; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

7.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

8.  Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Authors:  S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

9.  Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading.

Authors:  H Fudaba; T Shimomura; T Abe; H Matsuta; Y Momii; K Sugita; H Ooba; T Kamida; T Hikawa; M Fujiki
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

10.  Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Authors:  Gurpreet S Kapoor; Timothy A Gocke; Sanjeev Chawla; Robert G Whitmore; Ali Nabavizadeh; Jaroslaw Krejza; Joanna Lopinto; Justin Plaum; Eileen Maloney-Wilensky; Harish Poptani; Elias R Melhem; Kevin D Judy; Donald M O'Rourke
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.